Xenon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Xenon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 24c, Revenues Beat

August 6, 2020 5:03 PM EDT

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of $0.00, $0.24 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $13.38 million versus the consensus estimate of $6.9 million.

Dr. Simon Pimstone, Xenons Chief Executive Officer, said, Xenon continues to manage well as we respond to the global impacts of the COVID-19 pandemic. We are... More